by mobi | May 1, 2025
Yes. The Act mandates disclosure of agreements that result in direct or indirect benefits to HCPs or HCOs. Therefore, if an educational grant facilitates HCP attendance at events, those beneficiaries must be individually disclosed.
by mobi | May 1, 2025
Yes, your company is responsible for reporting if it manufactures or markets products in the Italian healthcare sector, regardless of having a physical presence in Italy. It's advisable to designate a local representative to manage compliance and communication...
by mobi | May 1, 2025
Previously, only members of industry associations like Farmindustria were required to disclose such information, often in aggregate form. The new Act supersedes these voluntary codes, enforcing mandatory, individual-level disclosures for a broader range of companies,...
by mobi | May 1, 2025
The Italian Sunshine Act (Law No. 62/2022) mandates pharmaceutical, medical device, and other healthcare-related companies to publicly disclose financial relationships with healthcare professionals (HCPs) and healthcare organizations (HCOs). This initiative aims to...
by mobi | May 1, 2025
Al momento, il modello ufficiale di segnalazione è in attesa di rilascio. Le aziende dovrebbero monitorare gli aggiornamenti del Ministero della Salute e preparare i propri sistemi interni per allinearsi ai requisiti che verranno stabiliti.
